Is a complete ALT research report available?

No complete published report is available for Altimmune, Inc. (ALT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Altimmune, Inc. (ALT)

NASDAQ: ALT · USD

$2.09

+0.05 (+2.5%)· Recorded snapshot

Market cap	406.5M
Revenue (ttm)	31K
Net income (ttm)	-91.8M
EPS (ttm)	-$0.73
Shares out	194.5M
Volume	3,842,735
Beta	0.06

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 31K
Net income (ttm): -91.8M
EPS (ttm): -$0.73
Market cap: 406.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001326190
Company name	Altimmune, Inc.
Country	United States
Country code	US
CUSIP number	02155H200
Earnings date	2026-11-09
Earnings time	bmo
Employees	57
Employees change	-2
Employees growth	-3.39%
Enterprise value	$116.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1997
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US02155H2004
Last 10-K release date	2026-03-06
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2018-09-14
Last stock split type	Reverse
Market cap	$406.5M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$2.09
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ALT
Tags	weight-loss
U.S. state	Maryland
Website	https://altimmune.com

Metric

Value

Amount currency

USD

CIK code

0001326190

Company name

Altimmune, Inc.

Country

United States

Country code

CUSIP number

02155H200

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-2

Employees growth

-3.39%

Enterprise value

$116.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1997

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US02155H2004

Last 10-K release date

2026-03-06

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2018-09-14

Last stock split type

Reverse

Market cap

$406.5M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$2.09

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ALT

Tags

weight-loss

U.S. state

Maryland

Website

https://altimmune.com

Metric	Value
Earnings yield	-34.73%
EV/Sales	3,437.26x
FCF / EV yield	-71.85%
FCF yield	-19.29%
P/B ratio	0.84x
P/S ratio	12,800.52x
Price / tangible book value	0.84x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-34.73%

EV/Sales

3,437.26x

FCF / EV yield

-71.85%

FCF yield

-19.29%

P/B ratio

0.84x

P/S ratio

12,800.52x

Price / tangible book value

0.84x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-318,493.55%
Pretax margin	-296,000%
Profit per employee	$-1.6M
Revenue per employee	$544
ROA	-17.2%
ROA (5Y)	-27.72%
ROCE	-19.18%
ROE	-28.87%
ROE (5Y)	-49.36%
ROIC	-17.95%
SBC / revenue	47,293.55%

Metric

Value

Operating margin

-318,493.55%

Pretax margin

-296,000%

Profit per employee

$-1.6M

Revenue per employee

$544

ROA

-17.2%

ROA (5Y)

-27.72%

ROCE

-19.18%

ROE

-28.87%

ROE (5Y)

-49.36%

ROIC

-17.95%

SBC / revenue

47,293.55%

Metric	Value
EPS growth quarters	8
EPS growth years	4
Net income growth years	1
Revenue growth	55%
Revenue growth 10Y	-39.42%
Revenue growth 5Y	-65.37%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

55%

Revenue growth 10Y

-39.42%

Revenue growth 5Y

-65.37%

Revenue growth years

Metric	Value
Capital expenditures	$-54,000
Depreciation and amortization	$99,000
EBIT	$-98.7M
EBITDA	$-98.6M
EPS	$-0.73
FCF per share	$-0.39
Financing cash flow	$410M
Free cash flow	$-76.6M
Free cash flow minus SBC	$-91.2M
Gross profit	$-66.7M
Investing cash flow	$-453.6M
Net borrowing	$20.4M
Net cash flow	$-120.1M
Net income	$-91.8M
Operating cash flow minus SBC	$-91.2M
Operating income	$-98.7M
Revenue	$31,000
Stock-based compensation	$14.7M

Metric

Value

Capital expenditures

$-54,000

Depreciation and amortization

$99,000

EBIT

$-98.7M

EBITDA

$-98.6M

EPS

$-0.73

FCF per share

$-0.39

Financing cash flow

$410M

Free cash flow

$-76.6M

Free cash flow minus SBC

$-91.2M

Gross profit

$-66.7M

Investing cash flow

$-453.6M

Net borrowing

$20.4M

Net cash flow

$-120.1M

Net income

$-91.8M

Operating cash flow minus SBC

$-91.2M

Operating income

$-98.7M

Revenue

$31,000

Stock-based compensation

$14.7M

Metric	Value
Altman Z-Score	3.35
Book value per share	$2.44
Debt / equity	0.08
Interest coverage	-27.92
Long-term assets	$192.4M
Long-term liabilities	$40.5M
Net cash (debt)	$290.3M
Net cash / market cap	73.15%
Net cash growth	73.54%
Net debt / equity	-0.61
Piotroski F-Score	3
Property, plant and equipment	$150,000
Shareholders' equity	$474.2M
Tangible book value	$474.2M
Tangible book value per share	$2.44
Total assets	$527.2M
Total cash	$326.3M
Total debt	$36M
Total liabilities	$53M
WACC	4.84%

Metric

Value

Altman Z-Score

3.35

Book value per share

$2.44

Debt / equity

0.08

Interest coverage

-27.92

Long-term assets

$192.4M

Long-term liabilities

$40.5M

Net cash (debt)

$290.3M

Net cash / market cap

73.15%

Net cash growth

73.54%

Net debt / equity

-0.61

Piotroski F-Score

Property, plant and equipment

$150,000

Shareholders' equity

$474.2M

Tangible book value

$474.2M

Tangible book value per share

$2.44

Total assets

$527.2M

Total cash

$326.3M

Total debt

$36M

Total liabilities

$53M

WACC

4.84%

Metric	Value
Asset turnover	0
Current assets	$334.8M
Current liabilities	$12.5M
Current ratio	26.78
Net working capital	$-3.7M
Quick ratio	26.37
Working capital	$322.3M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$334.8M

Current liabilities

$12.5M

Current ratio

26.78

Net working capital

$-3.7M

Quick ratio

26.37

Working capital

$322.3M

Working capital turnover

Metric	Value
Buyback yield / dilution	-68.9%
Dividend yield	0%
Shareholder yield	-68.9%

Metric

Value

Buyback yield / dilution

-68.9%

Dividend yield

Shareholder yield

-68.9%

Metric	Value
150-day SMA	$2.94
1D price change	2.45%
1M price change	-31.7%
1M total return	-31.7%
1W price change	-6.28%
1W total return	-6.28%
1Y price change	-49.52%
1Y return CAGR	-49.54%
1Y total return	-49.52%
20-day SMA	$2.39
200-day SMA	$3.30
3M price change	-29.39%
3M total return	-29.39%
3Y price change	-9.52%
3Y return CAGR	-3.28%
3Y total return	-9.52%
50-day SMA	$2.86
50-day SMA vs 200-day SMA	50under200
52-week high	$6.44
52-week high date	2026-01-23
52-week low	$2.00
52-week low date	2026-10-28
5Y price change	-81%
5Y return CAGR	-28.27%
5Y total return	-81%
6M price change	-25.36%
6M total return	-25.36%
All-time high	$237.30
All-time high date	2017-05-05
All-time low	$1.51
All-time low date	2019-11-19
Average true range (ATR)	$0.12
Average volume	3.8M
Beta (1Y)	2.04
Beta (2Y)	1.43
Beta (5Y)	0.06
Change from 52-week high	-67.55%
Change from 52-week low	4.76%
Change from all-time high	-99.12%
Change from all-time low	38.41%
Change from open	3.47%
Day's gap	-0.98%
Dollar volume	$8M
High price	$2.09
Low price	$2.00
Monthly RSI	39.42
Open price	$2.02
Position in 52-week range	100%
Premarket change	0.49%
Premarket close	$2.04
Premarket price	$2.05
Premarket volume	23.7K
Previous close	$2.04
Price vs 150-day SMA	-29.01%
Price vs 20-day SMA	-12.55%
Price vs 200-day SMA	-36.71%
Price vs 50-day SMA	-27.03%
Relative volume	1.02
RSI	25.75
Sharpe ratio	-0.69
Sharpe ratio (3Y)	0.43
Sharpe ratio (5Y)	0.07
Sortino ratio	-0.87
Sortino ratio (3Y)	0.71
Sortino ratio (5Y)	0.16
Volume	3.8M
Weekly RSI	32.59
YTD price change	-42.11%
YTD total return	-42.11%

Metric

Value

150-day SMA

$2.94

1D price change

2.45%

1M price change

-31.7%

1M total return

-31.7%

1W price change

-6.28%

1W total return

-6.28%

1Y price change

-49.52%

1Y return CAGR

-49.54%

1Y total return

-49.52%

20-day SMA

$2.39

200-day SMA

$3.30

3M price change

-29.39%

3M total return

-29.39%

3Y price change

-9.52%

3Y return CAGR

-3.28%

3Y total return

-9.52%

50-day SMA

$2.86

50-day SMA vs 200-day SMA

50under200

52-week high

$6.44

52-week high date

2026-01-23

52-week low

$2.00

52-week low date

2026-10-28

5Y price change

-81%

5Y return CAGR

-28.27%

5Y total return

-81%

6M price change

-25.36%

6M total return

-25.36%

All-time high

$237.30

All-time high date

2017-05-05

All-time low

$1.51

All-time low date

2019-11-19

Average true range (ATR)

$0.12

Average volume

3.8M

Beta (1Y)

2.04

Beta (2Y)

1.43

Beta (5Y)

0.06

Change from 52-week high

-67.55%

Change from 52-week low

4.76%

Change from all-time high

-99.12%

Change from all-time low

38.41%

Change from open

3.47%

Day's gap

-0.98%

Dollar volume

$8M

High price

$2.09

Low price

$2.00

Monthly RSI

39.42

Open price

$2.02

Position in 52-week range

100%

Premarket change

0.49%

Premarket close

$2.04

Premarket price

$2.05

Premarket volume

23.7K

Previous close

$2.04

Price vs 150-day SMA

-29.01%

Price vs 20-day SMA

-12.55%

Price vs 200-day SMA

-36.71%

Price vs 50-day SMA

-27.03%

Relative volume

1.02

RSI

25.75

Sharpe ratio

-0.69

Sharpe ratio (3Y)

0.43

Sharpe ratio (5Y)

0.07

Sortino ratio

-0.87

Sortino ratio (3Y)

0.71

Sortino ratio (5Y)

0.16

Volume

3.8M

Weekly RSI

32.59

YTD price change

-42.11%

YTD total return

-42.11%

Metric	Value
Float	164.3M
Float percentage	84.49%
Shares change (QoQ)	49%
Shares change (YoY)	68.9%
Shares held by insiders	0.48%
Shares held by institutions	62.77%
Shares outstanding	194.5M
Short % of float	28.04%
Short % of shares	23.69%
Short ratio	12 days

Metric

Value

Float

164.3M

Float percentage

84.49%

Shares change (QoQ)

49%

Shares change (YoY)

68.9%

Shares held by insiders

0.48%

Shares held by institutions

62.77%

Shares outstanding

194.5M

Short % of float

28.04%

Short % of shares

23.69%

Short ratio

12 days

Altimmune, Inc. (ALT)

Price

Financial snapshot

Fair-value bridge

Latest news · ALT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALT

Frequently asked questions